Clinical Trial Update: Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C [Phase 2]

View source ↗

Summary

Phase 2 trial update on Merimepodib (MMPD) in a triple-drug regimen for chronic hepatitis C; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Merimepodib (MMPD) (Merimepodib)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Hepatitis C, Hepatitis | Phase 2 | Status: COMPLETED